Himadri Speciality Chemicals shares gained 13% in Friday's intraday session, reaching a 14-month high of ₹605 apiece as investors responded positively to the company's March-ended quarter results. According to reports from Live Mint, the company reported a 13.5% year-on-year increase in consolidated revenue to ₹1,288 crore for Q4. Net profit surged 33.5% YoY to ₹207.53 crore, with EBITDA rising 21.15% YoY to ₹280 crore and operating margin expanding to 21.74%. For the full FY26, the company reported revenue of ₹4,660.70 crore and EBITDA of ₹755.07 crore, reflecting a 36% YoY EBITDA growth despite marginal 1% revenue growth.
The board has approved a proposal for the buyback of equity shares worth up to ₹180 crore at a price of ₹180 per share, comprising the purchase of 1 crore shares. As per latest market data, the stock was trading with volumes of 5,015,871 shares, compared to its five day average of 169,133 shares, showing an increase of 2,865.64% in trading activity. The promoters of the company have indicated their intention not to participate in the proposed buyback, indicating strong confidence in the company's future prospects and commitment to returning value to shareholders.
The company announced the commissioning of its first anode material production facility at Mahistikry, West Bengal, with an initial capacity of 200 MTPA. As reported by Live Mint, this backward integration, along with proprietary process know-how, enables a fully integrated and self-reliant manufacturing ecosystem across the anode material value chain. In FY26, the company commenced operations at its new 70,000 MTPA Speciality Carbon Black line at Mahistikry, taking total carbon black capacity to 250,000 MTPA, of which 130,000 MTPA is dedicated to special carbon black. According to CMD & CEO Anurag Choudhary, this positions Mahistikry as the world's largest single-location speciality carbon black site and places Himadri among the top five global manufacturers in this segment.
The company highlighted its focus on innovation-led R&D, which remains central to its strategy and business model. As reported by Live Mint, the upcoming anthraquinone and carbazole facility is on track to be commissioned in the coming quarters, aiming to reduce India's dependence on imports of dyes and pigments. Phase I of its LFP cathode material project is progressing as planned, with initial capacity expected by Q3FY27 and full operations targeted by FY29. The company emphasized its disciplined capital allocation approach to ensure sustainable returns and maintain a strong ROCE profile.
The stock delivered a 30% return in April after delivering muted returns over the previous three months, as reported by Live Mint. The rally has helped push its year-to-date returns to 17.30%. Earlier this year, the stock touched a low of ₹421 apiece and has since rebounded by 45% at current levels, marking a sharp turnaround from a 17% decline in CY25. Historically, the stock has delivered positive returns for four consecutive years from 2021 to 2024, with 2023 emerging as the best-performing year, recording a gain of 207%.
